Bionatrol Health, LLC
Agreed to an FTC consent order over allegedly unsupported health claims for its CBD oil
This entry is about the United States — not the country you picked in the header.
According to Federal Trade Commission, Dec 17, 2020 · Read the source · +1 more
- Where
- Utah, United States
- First reported
- Last checked
Resolved or closed
The source lists this matter as resolved or closed. The entry stays public so the record remains available.
Summary
Bionatrol Health, LLC and its affiliate Isle Revive LLC, Utah-based sellers of CBD oil, were among six companies named in the Federal Trade Commission's December 2020 sweep against deceptive CBD marketing, known as Operation CBDeceit. The FTC alleged that the companies, which had sold CBD oil through two websites since December 2019, claimed without adequate support that it was safe for everyone, treated pain better than OxyContin and could help with age-related cognitive decline, and that such benefits were medically proven. Under an administrative consent order finalized on March 5, 2021, the respondents agreed not to make disease-prevention or treatment claims without human clinical testing, to back other health claims with competent scientific evidence, to pay the FTC $20,000 and to notify customers about the order. The FTC lists the case as closed.
What the source found
- The FTC alleged unsupported claims that the CBD oil was safe for all users and treated pain better than OxyContin.
- The FTC also cited claims about age-related cognitive decline and claims that benefits were medically proven.
- The consent order bars prevention or treatment claims without human clinical testing and requires scientific evidence for other health claims.
- The respondents were required to pay $20,000 to the FTC and notify consumers of the order.
Products named
- CBD oil
Timeline
FTC announces administrative complaint and proposed consent order
FTC approves final decision and order; case closed
Sources
- Regulator
Federal Trade Commission · Dec 17, 2020
FTC Announces Crackdown on Deceptively Marketed CBD Products - Regulator
Federal Trade Commission · Mar 5, 2021
Bionatrol Health, LLC, In the Matter of
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
Settled through an administrative consent order in 2021; the FTC lists the case as closed. The order's restrictions on health claims remain in force. Current trading status of the business was not verified.
Comments
No comments yet.
Related entries
The full Red ListHerbal Pathways, LLC d/b/a HiBrid
HiBrid
Massachusetts regulator order over sales of products with out-of-date test results in Pittsfield
Empire 1 Convenience CORP
Empire 1 Convenience CORP
NYC Sheriff summons for a cannabis violation by a place of business
Purple Sky 1 CORP
Purple Sky 1 CORP
NYC Sheriff summons for a cannabis violation by a place of business
Tell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.